Cargando…
Advances in pharmacology. Volume 37 /
Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego :
Academic Press,
�1997.
|
| Colección: | Advances in pharmacology ;
v. 37 |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; Advances in Pharmacology, Volume 37; Copyright Page; Contents; Contributors; Chapter 1. Opioid and Nonopioid Cardiovascular Effects of Dynorphins; I. Introduction; II. The Central Dynorphinergic System; III. The Peripheral Dynorphinergic System; IV. Dynorphin and Cardiovascular Pathologies; V. Concluding Remarks; References; Chapter 2. Cytokines in Neuronal Development; I. Introduction; II. The Interleukin-6 Family: LIF, IL-6, CNTF, OncM, and G-CSF; III. Microglia; IV. Heparin-Binding Growth Factors (Other Than FGFs); V. Transforming Growth Factor Family.
- VI. Concluding ObservationsReferences; Chapter 3. Heterogeneity and Functional Properties of Subtypes of Sodium-Dependent Glutamate Transporters in the Mammalian Central Nervous System; I. Introduction; II. Identification of Na+-Dependent Glutamate Transport Systems; III. Na+-Independent Glutamate Transporters; IV. Pharmacological Heterogeneity of Na+-Dependent Glutamate Transporters; V. Molecular Properties of Subtypes of Na+-Dependent Glutamate Transporters; VI. Regulation and Alterations of Subtypes of Glutamate Transporters.
- VII. Functional and Pathological Roles of Glutamate Transport SystemsVIII. Conclusions and Future Directions; References; Chapter 4. Development and Therapeutic Potential of Calpain Inhibitors; I. Overview on Calpain; II. Development of Calpain Inhibitors; III. Therapeutic Areas; IV. Perspectives; References; Chapter 5. The Pharmacology of (
- )-Nicotine and Novel Cholinergic Channel Modulators; I. Introduction; II. Molecular Biology and Pharmacology of nAChRs; III. In Vivo Pharmacology of (
- )-Nicotine and Novel ChCMs; IV. Potential Therapeutic Effects of (
- )-Nicotine and Novel ChCMs.
- v. SummaryReferences; Chapter 6. Cryptococcosis; I. Introduction; II. Microbiology; III. Epidemiology; IV. Clinical Syndromes; V. Diagnosis; VI. Prognosis; VII. Treatment; VIII. Conclusions; References; Chapter 7. Antimalarial Activity of Artemisinin (Qinghaosu) and Related Trioxanes: Mechanism(s) of Action; I. Introduction; II. Background: Biology, Chemotherapy, Drug Resistance, and Artemisinin; III. Molecular Mechanism(s) of Action; IV. Outlook: Antimalarial Endoperoxides and Artemisinin Resistance; V. Conclusions; References.
- Chapter 8. The Role of Endothelin in the Pathogenesis of AtherosclerosisI. Introduction; II. Atherosclerosis: Lipoprotein Deposition to Plaque Rupture; III. Elevated Plasma Endothelin with Hyperlipidemia, Atherosclerosis, Transplantation Arteriosclerosis, and Diabetes; IV. Endothelin and Its Receptors in Atherosclerotic Lesions; V. Endothelin and Atherosclerosis: In Vivo Studies; VI. Stimuli for Endothelin Production; VII. Effect of Endothelin on Prostaglandin, Cytokine, and Chemokine Production; VIII. Endothelin Promotes Atherosclerosis: Potential Mechanisms.